Comparing two methods for treating fluid buildup in the lungs due to liver disease
Comparing Outcome of Thoracocentesis and Pigtail Catheter Drainage in Treatment of Patients With Hepatic Hydrothorax
NA · Sohag University · NCT06319547
This study is testing which method, between thoracocentesis and pigtail catheter drainage, works better to treat fluid buildup in the lungs for people with liver disease.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Sex | All |
| Sponsor | Sohag University (other) |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06319547 on ClinicalTrials.gov |
What this trial studies
This study compares the effectiveness of thoracocentesis and pigtail catheter drainage in treating patients with hepatic hydrothorax, a condition where fluid accumulates in the pleural cavity due to liver cirrhosis. The trial aims to determine which method provides better outcomes for patients suffering from this complication. Participants will be selected based on specific criteria related to their liver condition and the nature of their pleural effusion. The study is conducted at Sohag University hospitals, focusing on patients with liver cirrhosis and hepatic hydrothorax.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with liver cirrhosis who also have hepatic hydrothorax.
Not a fit: Patients with pleural effusions caused by conditions other than hepatic hydrothorax will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment options for patients with hepatic hydrothorax, enhancing their quality of life.
How similar studies have performed: While there have been studies on pleural effusions, this specific comparison of thoracocentesis and pigtail catheter drainage in hepatic hydrothorax is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who met the following inclusion criteria were enrolled: * Liver cirrhosis (with or without hepatocellular carcinoma). * Hepatic hydrothorax (bilateral or unilateral). Exclusion Criteria: * patients with a pleural effusion due to a condition other than HH. * who had a diagnosis of tuberculosis pleurisy, parapneumonic effusion, inflammatory pleuritis, other neoplasms, and congestive heart failure.
Where this trial is running
Sohag
- Sohag University hospitals — Sohag, Egypt (RECRUITING)
Study contacts
- Study coordinator: Aya A AbdElkareem, Resident
- Email: ayah.ashraf@med.sohag.edu.eg
- Phone: 01060342951
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hepatic Hydrothorax